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Research
Recent epidemiologic studies provide evi-
dence that an increase in atmospheric
nanoparticles (NPs) is associated with adverse
cardiovascular effects in susceptible parts of
populations (Ibald-Mulli et al. 2002;
Wichmann and Peters 2000; Wichmann
et al. 2000) such as the elderly and people
with underlying diseases of various origins
[U.S. Environmental Protection Agency
(U.S. EPA) 2004]. Clearance pathways of
inhaled nanoparticles (NPs) from the lungs
are assumed to differ from those of larger par-
ticles (> 100 nm diameter). In other words,
lung retention and clearance of NPs are
thought to be mediated less by alveolar
macrophages (AMs) than are those of larger
particles because AMs in vivo are not efﬁcient
in phagocytizing NPs—as they do in particles
> 100 nm (Kreyling and Scheuch 2000).
However, Semmler et al. (2004) found no
difference between pulmonary clearance
kinetics of NPs and that of larger particles,
suggesting that underlying clearance mecha-
nisms for different-sized particles ranging
from nano-sized to micron-sized might be the
same. This is puzzling given the discrepancy
between the very efficient phagocytosis of
micron-sized particles by AMs on the one
hand and the very inefficient uptake of NPs
by these cells on the other. How can these
opposite initial events of AM–particle interac-
tion lead to the same pulmonary clearance
kinetics for both particle types?
We hypothesize that the answer lies in the
well-described propensity of NPs deposited in
the lungs to translocate to epithelial cells
(ECs) and interstitium and, as suggested more
than 30 years ago by Brundelet (1965) and
Tucker et al. (1973), are carried via the lymph
flow to bronchial and bronchiolar sites,
including bronchial-associated lymphatic tis-
sue (BALT), where they are excreted again
into the airway lumen. Consistent with this
hypothesis, Ferin and Oberdörster (1992),
based on results from a rat inhalation study
with ultrafine (< 100 nm) titanium dioxide
(TiO2), reported histologic evidence for the
existence of two distinct clearance pathways
for particles in the peripheral lung via a) air-
ways and (b) the interstitial lymphatics and
back to the airways, and that these are inter-
connected. However, these authors also cau-
tioned that “it is difﬁcult to prove direction of
a clearance pathway from a static histological
observation,” which was the only evidence
they had. Thus, our aim in the present study
was to determine the clearance dynamics of
inhaled NPs retained in different compart-
ments of the rat’s lower respiratory tract over a
6-month period, with special attention to the
association of NPs with AMs.
Material and Methods
Approach. A common approach to investigat-
ing the clearance kinetics of particles in the
lungs is the use of poorly soluble particles
labeled with a convenient radioactive gamma
emitter. We found iridium-192 (192Ir) NPs to
be the appropriate material for studying clear-
ance kinetics because of the very low solubility
of Ir, even as an NP (Kreyling and Scheuch
2000; Semmler et al. 2004), although we are
aware that Ir is not a relevant component of
the ambient aerosol. In a previous study by
Kreyling et al. (2002), the authors found that
ultrafine poorly soluble 192Ir particles were
predominantly retained in the lungs during
the first week after inhalation. The NPs
deposited in thoracic airways and lung periph-
ery were cleared predominantly via airways
and larynx into the gastrointestinal tract
(GIT) and feces. Our goal in the present study
was to determine the long-term alveolar reten-
tion of these NPs and to compare our results
with those of Lehnert et al. (1989) for 2-µm
particles by analyzing retention kinetics in
different compartments of the lung. In the
study by Lehnert et al., the lavageable fraction
of 2-µm-sized instilled polystyrene particles
was quantitatively distinguished from the
nonlavageable fraction at various times during
6 months, which indicated that the vast
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BACKGROUND: There is ongoing discussion that inhaled nanoparticles (NPs, < 100 nm) may
translocate from epithelial deposition sites of the lungs to systemic circulation.
OBJECTIVES AND METHODS: We studied the disappearance of NPs from the epithelium by sequential
lung retention and clearance and bronchoalveolar lavage (BAL) measurements in healthy adult
Wistar Kyoto (WKY) rats at various times over 6 months after administration of a single 60- to
100-min intratracheal inhalation of iridium-192 (192Ir)–radiolabeled NPs. A complete 192Ir balance
of all organs, tissues, excretion, remaining carcass, and BAL was performed at each time point. 
RESULTS: Directly after inhalation we found free NPs in the BAL; later, NPs were predominantly
associated with alveolar macropages (AMs). After 3 weeks, lavageable NP fractions decreased to
0.06 of the actual NP lung burden. This is in stark contrast to the AM-associated fraction of
micron-sized particles reported in the literature. These particles remained constant at about 0.8
throughout a 6-month period. Three weeks after inhalation, 80% of the retained Ir NPs was
translocated into epithelium and interstitium. 
CONCLUSION: There is a strong size-selective difference in particle immobilization. Furthermore,
AM-mediated NP transport to the larynx originates not only from the NP fraction retained on the
epithelium but also from NPs being reentrained from the interstitium to the luminal side of epithe-
lium. We conclude that NPs are much less phagocytized by AMs than large particles but are effec-
tively removed from the lung surface into the interstitium. Even from these interstitial sites, they
undergo AM-mediated long-term NP clearance to the larynx.
KEY WORDS: alveolar macrophages, bronchoalveolar lavage, clearance, inhalation, nanoparticles,
reentrainment, relocation, retention, translocation. Environ Health Perspect 115:728–733 (2007).
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lung epithelium; this was achieved by dissolv-
ing tissue, then counting the ﬂuorescent parti-
cles. In a similar study in Syrian golden
hamsters, Ellender et al. (1992) obtained simi-
lar results after the hamsters inhaled micron-
sized glass particles. 
Animals.  Healthy, male WKY rats
(WKY/Kyo@Rj rats, Janvier, Le Genest Saint
Isle, France) 8–10 weeks of age and approxi-
mately 250 g body weight (bw) were housed
in pairs in a humidity-controlled (55% rela-
tive humidity) and temperature-controlled
(22°C) room in individually ventilated cages
(VentiRack, cage type CU-31; BioZone
Limited, Margate, Kent, UK), maintained on
a 12-hr day/night cycle. Rodent diet and water
were provided ad libitum. All animals used in
this study were treated humanely and with
regard for alleviation of suffering. The studies
were conducted under federal guidelines for
the use and care of laboratory animals and
were approved by the District of Upper
Bavaria, Approval No. 211-2531-108/99 and
by the GSF Institutional Animal Care and Use
Committee. 
Aerosol production and characterization.
The ultraﬁne 192Ir aerosol was produced using a
spark generator as described previously
(Kreyling et al. 2002). The spark frequency was
3 Hz in an argon stream of 3 L/min; immedi-
ately after condensational particle formation,
the aerosol was neutralized by an electric charge
with a radioactive krypton-85 source. The
aerosol then was diluted with nitrogen and
adjusted to 20% oxygen, 50–60% relative
humidity, and 37°C. This created a log normal
distribution of aerosol with a concentration of
1–3 × 107 cm–3 [continuously monitored by a
condensation particle counter (CPC 3022A;
TSI GmbH, Aachen, Germany) in a controlled
diluted aerosol sample], a count median diame-
ter (CMD) between 17–20 nm, and a geomet-
ric standard deviation of 1.6 [continuously
determined with a differential particle mobility
analyser (Classifier 3071 + CPC 3010; TSI
GmbH)]. Speciﬁc Ir activity was 10 GBq/g at a
reference date obtained by neutron activation of
the Ir electrodes of the spark generator in a
research reactor (Hahn-Meitner-Institute,
Berlin, Germany). Mass concentration was cal-
culated as 0.7 mg/m from the radioactivity
measurement of an integral ﬁlter sample and
the sampled aerosol volume.
Inhalation. To focus the analysis on the
kinetics of particle clearance from the lungs
unaffected by external contamination, we
avoided pelt contamination and particle depo-
sition in extrathoracic airways by using our
previously developed method of intratracheal
intubation inhalation. 
In preparation for the exposure, WKY rats
(32 in total, 4 at a time) were anaesthetized
with an intramuscular injection of a mixture of
medetomidine (15 µg/100 g bw), midazolam
(0.2 mg/100 g bw), and fentanyl (0.5 µg/100 g
bw). For endotracheal intubation, a flexible
cannula (16 ga, 2 inches in length) was placed
in the upper trachea under visual control and
sealed against outside air with a modified
pipette tip around the catheter wedged gently
into the laryngeal opening (Kreyling et al.
1993, 2002; Osier and Oberdörster 1997).
Each animal was placed in a self-made plethys-
mograph and connected with its endotracheal
cannula to the aerosol line outside of the
plethysmograph. The plethysmographs were
temperature controlled at 37°C. Ventilation
was computer controlled with a negative pres-
sure of –1.5 kPa applied to the plethys-
mograph for 1 sec of inspiration followed by
0.5 sec allowing spontaneous expiration to
functional residual capacity (FRC) at ambient
air pressure; the resulting breathing frequency
was 40 breaths/min. This ventilation pattern
caused inspiration from FRC to 75–80% of
total lung capacity of the rat; therefore, animals
were slightly hyperventilated and did not
breathe spontaneously but followed the com-
puter-controlled breathing pattern. For the
purpose of radiation protection, the entire
aerosol system was a) maintained at –30 Pa
low pressure on average and b) installed in a
glove box, which was ventilated continuously
through an absolute particle ﬁlter and main-
tained at –5 to –10 Pa below ambient air pres-
sure in the laboratory. 
After 60–100 min of inhalation, depending
on the anticipated deposited NP dose, rats were
removed from their plethysmographs, extu-
bated, and received an anesthesia antidote by a
subcutaneous injection of a mixture of atipa-
mezol (0.075 mg/100 g bw), flumazenil (20 µg/
100 g bw), and naloxone (10 µg/100 g bw).
Clearance and retention: NP clearance.
After exposure, rats were maintained in meta-
bolic cages for the ﬁrst 7 days, then singly in
individually ventilated cages. Excreta were col-
lected quantitatively throughout the study;
during the first week daily urine and feces
samples were collected separately in the meta-
bolic cages; later urine and feces samples were
collected together with the cage bedding for
periods of 3 days and up to 7 days. Fecal drop-
pings were separated from bedding to allow
for distinction of urinary excretion in bedding
from fecal excretion in droppings.
Deposition and terminal retention. At 0, 6,
and 24 hr, 3 and 7 days, 3 weeks, and 2 and
6 months after exposure, four rats each were
killed by exsanguinations after ip anesthesia
with ketamine (10 mg/100 g bw) and xylazine
(0.5 mg/100 g bw). Completely balanced reten-
tion of 192Ir activity retained in the body was
quantified by gamma spectroscopy in a 1-L
well-type scintillation detector (Eurisys/
Canberra, Rüsselsheim, Germany) corrected for
background radiation and detector geometry
and sensitivity. The total excreted fraction
throughout the entire study was also deter-
mined gamma spectroscopically. Hence, total
192Ir activity of retention plus excretion repre-
sents the initially deposited 192Ir activity.
Gamma camera image of 192Ir NP distri-
bution in the lungs. Excised lungs of rats
killed immediately after inhalation were
inflated to 3.5 kPa corresponding to total
lung capacity and air dried. The dried lungs
were subsequently placed under a single pho-
ton emission computed tomograph gamma
camera (SPECT) (Prism 2000; Philips Medizin
Systeme GmbH, Hamburg, Germany)
equipped with a pinhole collimator and
adjusted for gamma energy of 310 keV of
192Ir; images were collected for 24 hr. The pla-
nar image of the activity distribution was com-
pared with digital photographs resembling the
same optical geometry for qualitative checking
of homogeneous 192Ir activity distribution
throughout the lungs and their periphery.
Bronchoalveolar lavage (BAL). At the
above-mentioned time points, BAL was per-
formed. After perforating the diaphragm, 5 mL
phosphate-buffered saline (PBS) without Ca2+
and Mg2+ was administered 6 times into the
lungs in situ under gentle massage of the thorax
and recovered. The recovered BAL ﬂuid (about
90% of instilled saline) was centrifuged at
500 g, for 20 min at 20°C, and lavaged cells
were separated from supernatant. The total
number of lavaged cells was counted with a
hemocytometer by a dilute of the spun-down
cells. Viable cells were distinguished by exclu-
sion of trypan-blue staining. Free NPs un-
attached to BAL cells were recovered in the
supernatant of the recovered BAL fluid.
Lavaged cell numbers and cell viability were
determined using a hemocytometer. Cyto-
centrifuged slides of spun-down lavaged cells
were prepared for each animal and stained with
Diff-Quik (Dade Behring, Newark, DE, USA)
for cell differential counts. The 192Ir activity
within the lavaged cells and in the supernatant
was quantified by gamma spectroscopy in a
1-L well-type scintillation detector. 
Lavageable fraction of NPs in WKY rats.
Because of the very low solubility of the 192Ir
particles, the measured 192Ir activity in both
fractions of BAL is particle associated, and the
dissolved fractions are negligible. In addition,
we proved that free ultraﬁne 192Ir particles in
saline were not significantly (< 2%) spun
down under the conditions of centrifugation
chosen. Hence, 192Ir radioactivity determined
in the lavaged cell pellets represents 192Ir parti-
cles either phagozytized by or adherent to
AMs, whereas the activities in the supernatants
represent free 192Ir particles in the BAL ﬂuid.
Data analysis. Retention and excretion
data were normalized and expressed as frac-
tions of the initial lung burden. In addition,
fractional rates of lavaged and excreted 192Ir
Nanoparticles two-way transport across lung epithelium
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temporary lung burden at given time points
when indicated. 
All radioactivity data were background-
corrected and calculated for the date of
neutron activation.
Results
Deposition. Deposited 192Ir doses of the
exposed rats at the various time points were
shown previously (Semmler et al. 2004).
Recalculation of these data yielded a
mean-deposited Ir mass of 2 µg/rat during the
1-hr exposure with the exemption of the
6-month study in which we increased the
exposure time by a factor of 1.7, resulting in
an increased deposited Ir mass of 3.5 µg/rat. 
As shown earlier, the ultrafine 192Ir-
labeled particles were virtually insoluble
(< 1% of Ir mass within 7 days of incubation
in PBS). Therefore, radioactivity measure-
ment is proportional to the mass of the ultra-
ﬁne Ir particles.
Particle distribution in the lungs.
Distribution patterns of inhaled 192Ir NPs in
the rat lungs were acquired with SPECT
gamma camera images. These images showed
radioactivity throughout the rat lungs after
inhalation of 192Ir NPs by the intubated and
ventilated rats (Figure 1). Note, however, the
resolution of the gamma camera does not
allow distinguishing between alveolar region
and bronchial region of the rat lungs. 
Particle retention and clearance.
Depostion and long-term particle retention
and clearance kinetics were reported in detail
recently (Semmler et al. 2004). 
Bronchoalveolar lavage (BAL). Figure 2
compares the retention of total Ir NPs in the
lungs with the lavaged fractions throughout the
6-month period; fractions are normalized to the
initially deposited lung burden. During the ﬁrst
2 months, the recovered NP fraction drops
much faster in BAL than in lungs. Thereafter,
BAL and lung fractions run parallel.
Data for NPs accessible to BAL were
reported recently (Semmler et al. 2004) and are
shown in Table 1. The fraction of polymor-
phonuclear leukocytes (PMNs) showed a mod-
erate increase immediately after the 1-hr
ventilation of intubated rats. The elevated frac-
tion persisted for 24-hr. Three days and longer
after inhalation, PMNs of the BAL cell count
had decreased to a physiologic control level of
about 0.7 %; therefore, this transient and
minor inﬂammation is not expected to affect
the long-term clearance of the inhaled NPs.
Because similar elevated fractions of PMNs
have been observed 1 day after clean air intra-
tracheal intubation inhalation, the ventilation
via the endotracheal tube appears to be the
cause of this transient inﬂammatory reaction. 
The average number of lavaged cells over
all individual BALs of Ir NP–exposed rats 
was 3.7 ± 3.13 × 106. The high cell count at
21 days after inhalation is unexplained, as
there was no observed adverse response.
Free NP fraction in BAL. Immediately
after 192Ir NP inhalation, a fraction (NPlav) of
0.46 of the deposited NP was recovered by
BAL (Table 1). Of this NPlav, only an NP frac-
tion of 0.22 ± 0.05 was in the cell pellet (NPCP)
and 0.78 were free NPs in the supernatant. The
NPCP fraction in the cell pellet increased rapidly
on the ﬁrst day. At day 3 only about 5–10% of
the lavaged NPs were free in the BAL fluid.
This is in agreement with studies using
Semmler-Behnke et al.
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Figure 1. (A) SPECT gamma camera (Prism 2000; Philips) image of 192Ir activity distribution in the dried
lungs applying a pinhole collimation geometry. (B) Air-dried rat lungs, immediately removed after inhala-
tion and air dried at total lung capacity, dorsal view; bar = 10 mm.
A B
Figure 2. (A) Lung retention, cumulative fecal excretion, and lavaged fraction of 192Ir NPs with 17- to 20-nm
median diameter during 6 months after a single 1- to 1.5-hr inhalation. (B) Expands the data of the ﬁrst week
after inhalation. Total lung retention data are the sum of measured lung and BAL fraction from each ani-
mal. All fractions are normalized to the initially deposited 192Ir NPs in the lungs. At each time point, data
obtained from four rats are averaged and error bars indicate SD.
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fractions of free particles even 6 hr after inhala-
tion (Brain 1985). In Figure 3 the lavaged NP
fractions and those of free NPs compared with
AM-associated NPs are plotted relative to the
initial lung deposit, thereby indicating a sharp
decrease of the free NPs, in particular; the free
NP fraction dropped rapidly to about 1%
during the ﬁrst week and < 0.1% later. 
Discussion
The 192Ir particles appeared to be suitable for
these studies because of their very low in vitro
solubility and their simple biokinetics shown
in previous investigations (Kreyling et al.
2002; Semmler et al. 2004). Administering
the aerosol via an endotracheal tube allowed
thoracic particle deposition and quantitatively
balanced clearance measurements to begin
immediately after inhalation, as no particles
deposited in extrathoracic airways or contami-
nated the pelt. It is important to consider that
the 1-hr procedure of intubated ventilation is
likely to initiate a transient inﬂammation dur-
ing the ﬁrst hours after inhalation. 
Ultraﬁne Ir NPs, 17–20 nm, were retained
mainly in the lungs. At any time, NPs were
cleared predominantly from the peripheral lung
via the airways into the GIT and were found in
feces (Semmler et al. 2004). Fecal excretion
throughout the entire study of retention con-
firmed the predominance of this clearance
pathway as shown previously. 
Only directly after and 6 hr after Ir parti-
cle inhalation, was an appreciable amount of
free particles found in the BAL ﬂuid. At later
times this fraction almost diminished. As a
result, nearly all Ir NPs were associated with
AMs in the BAL fluid. Interestingly this
lavageable NP fraction declined to < 0.2 of
the totally retained NPs over time. These
fractions were much lower than the 0.8 frac-
tions reported in studies using micron-sized
particles (Ellender et al. 1992; Lehnert et al.
1989). In contrast, the daily cleared NP frac-
tions in larynx and fecal excretions were simi-
lar to those measured for micron-sized
particles as dicussed earlier (Semmler et al.
2004). To better understand the biokinetic
fate of NPs while being retained in the lungs,
we performed an additional analysis and com-
parison with existing data for micron-sized
particles. These yielded three results, some of
which had been hypothesized in the past: 
• The major fraction of Ir NPs disappeared
from the epithelial surface and were relo-
cated within the epithelium and in the inter-
stitium (Oberdörster et al. 2000, 2005). 
• Surprisingly, from this interstitial NP frac-
tion, Ir NPs continued to reentrain back
onto the lung epithelium adding to the
macrophage-mediated clearance transport to
the larynx and fecal excretions (Ferin and
Oberdörster 1992; Green 1973).
• Ir NP translocation into circulation was
measurable as we showed previously, but
the fraction was much less than that re-
entraining back onto the epithelium.
Determination of total AM population in
WKY rats. Lehnert et al. (1989) used an
“exhaustive” lavage technique that enabled
recovery of 78% of the total AM population in
Fischer-344 rats. Lungs were removed and
lavaged 20 times using 5 mL PBS each. Because
our lavage technique was not as exhaustive as
that derived by Lehnert and co-workers, it
Nanoparticles two-way transport across lung epithelium
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Table 1. Cell counts and NP fractions in BAL ﬂuid (mean ± SD; n = 4 WKY rats at each time point).a
Total no. of lavaged PMNs
Time after inhalation cells (× 106) (%) NPlav
b NPCP
c
Untreated healthy adult male WKY rats
Control rats, nonexhaustive BAL 4.2 ± 0.45 0.7 ± 0.17
Control rats, exhaustive BAL 9.76 ± 0.61 0.88 ± 1.13
Clean air–exposed ventilated and intubated rats
Control rats, exhaustive BAL 7.80 ± 0.28 3.67 ± 2.42
1 day
Ir NP–exposed ventilated and intubated rats
0 hr 3.2 ± 0.1 4.05 ± 1.38 0.46 ± 0.05 0.22 ± 0.05
0.25 days 3.5 ± 1.2 6.41 ± 1.86 0.19 ± 0.03 0.62 ± 0.26
1 day 4.0 ± 1.0 5.88 ± 1.19 0.14 ± 0.03 0.71 ± 0.13
3 days 5.5 ± 1.4 1.25 ± 0.71 0.14 ± 0.03 0.92 ± 0.18
7 days 5.9 ± 1.1 0.55 ± 0.76 0.17 ± 0.04 0.84 ± 0.14
21 days 9.5 ± 3.7d 1.00 ± 0.71 0.06 ± 0.04 0.97 ± 0.66
60 days 1.8 ± 0.3 0.36 ± 0.48 0.05 ± 0.02 0.93 ± 0.28
168 days 2.4 ± 0.3 0.19 ± 0.24 0.07 ± 0.03 0.94 ± 0.38
Abbreviations: NPCP, nanoparticle fraction in the cell pellet of NPlav; NPlav, lavaged NP fraction of BAL; PMNs, polymor-
ponuclear leukocytes.
aControls for total cell numbers and PMNs were untreated. bData were normalized to the contemporary particle burden in
the lungs (normalized to the deposited particle burden minus the already excreted fraction). cData were normalized to the
totally lavaged particles in pellet and supernatant of BAL. dLavaged cell counts were very high without any indication for
further health implications.
Figure 3. (A,B) 192Ir NP fraction of lung deposit as determined from 192Ir radioactivity measurements in cells
and supernatant after separation by centrifugation of the BAL at different time points. (B) Expands the data of
the ﬁrst week after inhalation. All fractions are normalized to the initially deposited 192Ir NP in the lungs. At
each time point, data obtained from four rats are averaged and error bars indicate SD. 
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likely did not reach the entire epithelial surface
of the lungs. Therefore, we attempted to apply
their technique to estimate the AM population
in our WKY rats. According to this protocol we
obtained 9.76 ± 0.61 106 AMs in three
untreated adult healthy WKY rats. Assuming
the same mean AM recovery efﬁciency of 78%
Lehnert and co-workers observed, the corre-
sponding total AM population was 12.5 ± 0.8
106 AMs in our WKY rats. 
Estimated NP fraction on the epithelial
surface. To conservatively estimate the NP
fraction associated with the entire AM popula-
tion (NPAM) on the epithelial surface, we mul-
tiplied the NP fraction observed in the cell
pellet by the ratio of the total AM population
of 12.5 × 106 AM over the actually lavaged
AM fraction at each time point given in
Table 1. Estimated NPAM is shown in
Figure 4. Although about 0.35 of the retained
NPs was associated with AMs during the ﬁrst
week after inhalation, this fraction decreased
slightly to about 0.2 during the time remain-
ing. This is in clear contrast to the lavaged
polystyrene particle (PSL) fractions in AMs,
with a range of 0.8 of the lung burden as deter-
mined by Lehnert et al. (1989; Figure 4). In a
comparable study on Syrian hamsters, Ellender
et al. (1992) obtained fractions in BAL similar
to those in the Lehnert study after the inhala-
tion of glassy micron-sized glass particles.
To estimate the total free NP fraction
(NPfree) on the epithelium, we performed the
same type of estimate as for the NPAM, while
basically correcting for the incomplete lavage
procedure of the epithelial surface. Because
the observed free NP fractions are very small
1 week after inhalation and later, the cor-
rected fractions are still rather small and con-
tribute little to the NP fraction on the
epithelial surface. Estimated NPfree on the
epithelium are shown in Figure 5.
Relocation of NPs into and through the
epithelium. Immediately after inhalation we
were able to lavage free NPs from the epithe-
lial surface (Table 1); of the lavageable NP
fraction, 0.78 were free NPs. However, at
later time points we found only negligible
fractions of free NPs in BAL supernatant,
clearly indicating that almost all NPs were
associated either with AMs or with ECs, or
were in the interstitial compartment. In addi-
tion, the lavageable NPCP fraction associated
with AMs declined rapidly so that the NP
fraction retained in the lungs after lavage was
about 0.85 of the contemporary lung burden
during the ﬁrst 3 weeks after inhalation; later
it was higher than 0.90 (Table 1). Our con-
servative estimates to correct for either free or
AM-associated NPs only slightly increased
these fractions.
Although we principally cannot exclude
that NPs stayed on the epithelium being ﬁrmly
bound to ECs and were not accessible to
lavage, it appears unlikely that the NPs con-
tinue to remain attached on the epithelium for
as long as 6 months. In fact, NP binding to
ECs should occur very rapidly, within seconds
to minutes after deposition. This was not
observed immediately after the 1-hr inhalation,
at which time we were able to lavage a large
fraction of free NPs. Therefore, we conclude
that nonlavageable NP fractions retained
longer than 3 days in the lungs were either
internalized in ECs or had already been relo-
cated into interstitial spaces. Furthermore, only
negligible NP fractions were translocated to
secondary target organs probably via blood cir-
culation. Previously we have shown that this
translocated NP fraction was < 1% of the
deposited particles (Semmler et al. 2004). This
relocated fraction (NPreloc) derived from
NPreloc = 1–(NPfree + NPAM) is shown in
Figure 5.
These results are qualitatively conﬁrmed by
a number of morphologic studies: Takenaka
et al. (2006) showed uptake in type I epithelial
cells, endothelial cells, and the alveolar septum
of ultraﬁne gold-particles by transmission elec-
tron microscopy, respectively, but found very
few NPs on the epithelium. Furthermore,
Ferin and co-workers had shown the uptake of
20-nm ultrafine TiO2-particles in epithelial
cells and in the interstitial spaces (Ferin et al.
1992; Oberdörster et al. 1994). Geiser et al.
(2005) showed that 1 hr after inhalation, 24%
of inhaled 22-nm TiO2 particles were within
or beyond the epithelial barrier of the lungs in
epithelial and endothelial cells, connective tis-
sue, or capillaries. Collectively, these studies
showed that NPs penetrated into and beyond
the epithelium rather rapidly. Furthermore,
several publications have reported translocation
into systemic circulation and accumulation in
secondary target organs; these publications
have been reviewed recently (Oberdörster et al.
2005). This is different from epithelial surface
retention observed for micron-sized poly-
styrene and glass particles (Lehnert et al. 1989;
Oberdörster et al. 1994). Our data do not pro-
vide any information about the interstitial
localization of retained NPs. Ferin and
Oberdörster (1992) discussed the role of
BALT as a possible site in rats where interstitial
particles move out onto the bronchiolar
mucosa. Green (1973) also suggested that in
rodent lungs, coal-laden macrophages and par-
ticles exit onto airways in the same direction.
Reentrainment of NPs from interstitium
onto airways epithelium. As described previ-
ously (Semmler et al. 2004), long-term particle
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Figure 4. NPlav and estimated NP fraction retained
in the NPAM together with biexponential fit: half-
lives 2 and 800 days. In comparison, lavaged PSL
fraction (2.1-µm polystyrene particles) in AMs are
plotted together with a trend line as reported by
Lehnert et al. (1989). All lavaged particle fractions
are normalized to contemporary particle burden in
the lungs.
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Figure 5. Estimated fraction of translocated NP into
epithelium and interstitium as NPreloc = 1–(NPfree +
NPAM) with biexponential fit (half-lives 5 and 400
days) and the estimated fraction of NPfree. NPreloc,
relocated fraction. For comparison, the NPAM data
and the fitted curve of the AM-associated NP of
Figure 4 are given. All NP fractions are normalized
to contemporary particle burden in the lungs.
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Figure 6. Estimated NP clearance from NP fraction retained on the epithelial surface versus observed
daily fecal excretion as the result of AM-mediated NP transport from the lungs to larynx.Nanoparticles two-way transport across lung epithelium
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clearance of both ultrafine and micron-sized
particles was dominated by macrophage-
mediated particle transport from the peripheral
lungs to the larynx, with subsequent passage
through the GIT and fecal excretion. The
kinetics of daily cleared particle fractions did
not differ between ultraﬁne and micron-sized
particles. The latter was demonstrated by the
kinetics of fecal excretion rates (CRs) of poorly
insoluble, micron-sized glass particles obtained
from two strains of rats, Wistar-derived HMT
rats and Fischer-344 rats (Semmler et al. 2004;
Figure 4) as expressed by the equation: 
CR = 0.019 exp(–0.018 t) 
+ 0.0045 exp(–0.0039 t), 
where t is time in days (Kreyling 1990). 
This result is indeed surprising, as NPs are
predominantly translocated and retained
beyond the epithelium, whereas most of the
micron-sized PSLs were retained in AMs on
the epithelium. If NP clearance had occurred
only from the top of the epithelium, we can
estimate this clearance kinetics from the
above-calculated fractions of free and AM-
associated Ir NPs and the clearance rates of the
equation for CRs (Kreyling 1990). The curve
is much lower than the observed excretion
rates for Ir NPs shown in Figure 6. Therefore,
the observed excretion rates representing
macrophage-mediated NP transport from the
peripheral lung epithelium to the larynx can
be explained only by the fact that NPs—
relocated and retained beyond the epithelial
surface—needed to re-enter from the epithe-
lium and interstitium onto the luminal side to
get access to particle transport to the larynx as
well as to BAL. This process of NP clearance
from interstitial spaces and reentrainment on
the epithelium appears to be continuous
throughout the observed retention period as
shown in Figure 6. The predominant fraction
of phagocytized NPs at any long-term reten-
tion time point suggests that this reentrain-
ment of the particles at the epithelial surface
may be macrophage mediated; at least the very
small fractions of free NPs in the BAL samples
are suggesting this mechanism.
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